Rosalia Ferraro | Chemical Engineering | Innovative Research Award

Published on by Global CAD Awards

Innovative Research Award

Rosalia Ferraro
Università degli Studi di Napoli Federico II, Italy

Rosalia Ferraro
Affiliation Università degli Studi di Napoli Federico II
Country Italy
Scopus ID 57219198711
Documents 20
Citations 238
h-index 9
Subject Area Chemical Engineering
Event Global Cad Awards

Rosalia Ferraro is recognized for research contributions in soft matter physics, rheological characterization, cancer biomechanics, colloidal systems, drug delivery technologies, and computational biomedical modeling. Her work bridges fundamental physical sciences with biomedical and industrial applications.[1]

Abstract

This article summarizes the academic profile and research achievements of Dr. Rosalia Ferraro in soft matter physics, rheology, biomechanics, biomedical engineering, and computational modeling. Her interdisciplinary investigations contribute to understanding complex fluids, cellular mechanics, cancer biomechanics, and advanced therapeutic systems.[2]

Keywords

Soft Matter Physics, Rheology, Cancer Biomechanics, Cell Spheroids, Drug Delivery Systems, Complex Fluids, Biomedical Engineering, Computational Modeling.

Introduction

Modern soft matter research plays a central role in healthcare technologies, materials science, and industrial innovation. Understanding rheological behavior and biomechanical responses enables advances in diagnostics, therapeutics, and functional materials.[3]

Research Profile

Ferraro’s research portfolio encompasses rheological characterization of complex fluids, soft matter systems, cancer biomechanics, cellular mechanics, and biomedical engineering applications. Her work demonstrates strong interdisciplinary integration across physics, engineering, and life sciences.[1]

Research Contributions

  • Rheological characterization of soft matter and surfactant systems.
  • Cancer biomechanics and tumor spheroid modeling.
  • Cellular morphology studies under shear flow conditions.
  • Advanced drug delivery system development.
  • Computational and experimental approaches to biomedical mechanics.

Publications

  • The Dilemma of Cancer Biomechanics Assessment: Living Soft Matter from a Rheological Perspective (2026)..[4]
  • Quantifying Invasive Potential in Cell Spheroids via Shear-Induced Erosion and Tomographic Shape Reconstruction (2026).
  • The Morphology of Cell Spheroids in Simple Shear Flow (2024)..[5]
  • Designing Advanced Drug Delivery Systems Through Electro-Fluid Dynamic Atomization (2024).
  • Hybrid Cellular Automata Modeling Reveals the Effects of Glucose Gradients on Tumour Spheroid Growth (2023).

Research Impact

The scientific contributions of Dr. Ferraro have strengthened understanding of complex fluid behavior, cancer cell mechanics, rheological methodologies, and translational biomedical technologies. Her publications demonstrate relevance to both fundamental science and applied innovation.[2]

Award Suitability

The interdisciplinary scope of Dr. Ferraro’s research, together with her contributions to rheology, biomechanics, biomedical engineering, and soft matter science, aligns strongly with the objectives of a Research Excellence Award recognizing innovation and scientific impact.[3]

Conclusion

Through sustained contributions to soft matter physics, rheology, cancer biomechanics, and biomedical technologies, Dr. Rosalia Ferraro has established a distinguished research profile characterized by interdisciplinary collaboration, scientific rigor, and translational relevance.[1]

References

    1. Google Scholar. (2026). Rosalia Ferraro – Scholarly Publications and Citation Profile. 

      https://scholar.google.com/citations?user=NWl2lKIAAAAJ&hl=en&oi=sra

    2. Scopus Profile  Rosalia Ferraro – Scholarly Publications and Citation Profile. 

      https://www.scopus.com/authid/detail.uri?authorId=57219198711

    3. Orcid. Rosalia Ferraro – Scholarly Publications and Citation Profile. 

      https://orcid.org/0000-0003-1443-4160

    4. Ferraro, R. et al. (2026). The Dilemma of Cancer Biomechanics Assessment: Living Soft Matter from a Rheological Perspective. 

      https://www.sciencedirect.com/science/article/pii/S2590006426001316

    5. Ferraro, R. et al. (2024). The Morphology of Cell Spheroids in Simple Shear Flow. 

      https://www.frontiersin.org/journals/physics/articles/10.3389/fphy.2024.1347934/full

Francisco Ciruela|Bioengineering| Best Researcher Award

Published on by Global CAD Awards

Prof.Francisco Ciruela|Bioengineering| Best Researcher Award

Professor of Pharmacology,University of Barcelona,Spain

 

Professor Francisco Ciruela has built an outstanding research career around the pharmacological modulation of GPCRs, particularly through photopharmacology and bioengineering, with far-reaching implications in pain, neurodegeneration, and dermatological disorders. His publication impact, scientific leadership, and multidisciplinary collaborations reflect excellence, innovation, and relevance in his field.

 

Profile:

Scopus

 

Education and Training:

Prof. Francisco Ciruela received his Bachelor of Science in Biological Sciences from the University of Barcelona in 1990. He continued at the same institution to earn his Ph.D. in Biological Sciences in 1995. His academic foundation laid the groundwork for an accomplished career in pharmacology and neuroscience, particularly in the study of G protein-coupled receptors (GPCRs).

Professional Experience:

Prof. Ciruela has held various prestigious research and academic positions. He was an EMBO Fellow and then a Wellcome Trust Fellow at the University of Oxford between 1997 and 2000. In 2002, he began his academic career as an Assistant Professor at the University of Barcelona, later becoming a “Ramón y Cajal” Researcher from 2003 to 2007. He undertook a short-term fellowship in 2007 at Harvard Medical School and served as a Special Visiting Researcher in Brazil between 2012 and 2015. Since 2013, he has been a Guest Professor at Ghent University, Belgium. He has also served as the Rector’s Delegate for Strategic Research Actions at the University of Barcelona (2017–2020) and is currently the Coordinator of the Neuroscience Program at IDIBELL, Spain.

Skills and Expertise:

Prof. Ciruela is a leading expert in neuropharmacology, molecular pharmacology, and bioengineering, with deep specialization in GPCR biology. His technical expertise includes fluorescence-based biosensors, photopharmacology, and bioengineered tools for studying neurotransmission, pain, and neurological disorders. He also has extensive experience in coordinating interdisciplinary teams, clinical trials, and translational research.

Research Focus:

The core of Prof. Ciruela’s research lies in understanding GPCRs to develop novel pharmacological strategies for treating neurological, neuropsychiatric, and pain-related disorders. His work integrates advanced bioengineering techniques with pharmacology to create targeted and photo-controllable therapies. His lab also focuses on developing innovative technologies such as light-sensitive ligands and biosensors, bridging basic neuroscience with clinical applications.

Awards and Honors: 

Prof. Ciruela’s work has been widely recognized. He received the Pharmacology Award from the Spanish Society of Pharmacology and Almirall Laboratories in 2008. In 2010, he was honored with the “ICREA Acadèmia” award from the Catalan Institution for Research and Advanced Studies. In 2017, he received the prestigious Grünenthal Foundation Award for his contributions to pain research.

Publications:

1. Temporomandibular disorders and mental health: shared etiologies and treatment approaches

Authors: Wan, Jiamin; Lin, Jiu; Zha, Tingfeng; Chen, Qianming; Chen, Xiaoyan

Year: [Not specified]

Citations: 0

Type: Article • Open access

2. Striatal dopamine D2, adenosine A2A and cannabinoid CB1 receptors balance as a target against non-cognitive symptoms in a mouse model of Alzheimer’s disease

Authors: Gómez-Acero, Laura; Sánchez-Fernández, Nuria; Subirana, Paula; Ciruela, Francisco; Aso, Ester

Journal: Pharmacology, Biochemistry and Behavior

Year: 2025

Citations: 0

Type: Article • Open access

3. Nanoarchitecture of CaV2.1 channels and GABAB receptors in the mouse hippocampus: Impact of APP/PS1 pathology

Authors: Martín-Belmonte, Alejandro; Aguado, Carolina; Alfaro-Ruíz, Rocío; Ciruela, Francisco; Luján, Rafael

Journal: Brain Pathology

Year: 2025

Citations: 1

Type: Article • Open access

4. Author Correction: Systematic protein-protein interaction mapping for clinically relevant human GPCRs

Authors: Sokolina, Kate; Kittanakom, Saranya; Snider, Jamie D.; Jurisica, Igor; Stagljar, Igor

Journal: Molecular Systems Biology (Correction for 2017 article)

Year: [Correction date not specified]

Citations: 0

Type: Erratum • Open access

5. Lessons from the physiological role of guanosine in neurodegeneration and cancer: Toward a multimodal mechanism of action?

Authors: Tasca, Carla Inês Inês; Zuccarini, Mariachiara; Di Iorio, Patrizia; Ciruela, Francisco

Year: [Not specified]

Citations: 1

Type: Review

6. The dopaminergic effects of esketamine are mediated by a dual mechanism involving glutamate and opioid receptors

Authors: Rizzo, Arianna; Garçon-Poca, Maria Zelai; Essmann, Amelie; Ciruela, Francisco; Bonaventura, Jordi

Journal: Molecular Psychiatry

Year: 2025

Citations: 0

Type: Article • Open access

 

Conclusion:

Prof. Ciruela exemplifies the qualities of a best-in-class researcher: scientific excellence, innovation, interdisciplinary impact, and translational relevance. His record aligns perfectly with the aims of a prestigious research recognition award and would reflect well on any institution granting it.

Christian Poets| Medizintechnik | Excellence in Innovation

Published on by Global CAD Awards

Prof .Christian Poets| Medizintechnik | Excellence in Innovation

Prof , Christian Poets,Universitätsklinikum Tübingen, Germany.

Professor Christian Poets is a renowned expert in neonatology and pediatric respiratory medicine at Universitätsklinikum Tübingen, Germany. He is recognized for his pioneering work in neonatal care, particularly focusing on respiratory disorders in newborns and preterm infants. Prof. Poets has contributed extensively to clinical research in infant sleep, breathing patterns, and Sudden Infant Death Syndrome (SIDS), improving both diagnostic and therapeutic approaches in neonatology. His research has had a significant impact on reducing infant mortality rates and enhancing care for preterm babies worldwide.

Summary:

Prof. Christian Poets is a highly accomplished researcher and clinician with a long track record of innovation in neonatology and pediatric care. His leadership in multicenter clinical trials and his contributions to both respiratory and craniofacial malformations research make him an outstanding candidate for the Research for Excellence in Innovation Award. His work spans clinical innovation, large-scale research, and interdisciplinary care, all of which contribute to advancing pediatric health care worldwide.

Professional Profiles:

Scopus

🎓 Education :

Christian F. Poets, MD, graduated from Hannover Medical School, Germany, in June 1986. He received his post-graduate medical training at the Department of Paediatric Pulmonology & Neonatology at Hannover Medical School, focusing on pediatric care. To further his expertise in sudden infant death syndrome (SIDS) research, he underwent specialized training at the Department of Paediatric Respiratory Physiology, Brompton Hospital & National Heart & Lung Institute, London, UK.

🏢 Experience:

In 1994, Dr. Poets was appointed Director of the Neonatal Intensive Care Unit and Paediatric Sleep Laboratory at Hannover Medical School. His leadership extended to the University of Tuebingen, Germany, where, since 2002, he has served as Chair and Medical Director of the Department of Neonatology. Additionally, in 2008, he became Chairman of the Interdisciplinary Centre for Cleft Palate and Craniofacial Malformations at Tuebingen University Hospital. Between 2020 and 2023, he also held the role of Acting Medical Director of Tuebingen University Children’s Hospital. He further enhanced his global profile by serving as a visiting professor at the Royal Children’s Hospital in Hobart, Australia, in 2019/2020 and again in early 2024.

🛠️Skills:

Dr. Poets’ expertise lies in neonatal care, pediatric sleep disorders, and the management of craniofacial malformations. His in-depth understanding of clinical trial coordination, combined with his experience in perinatal epidemiology, makes him a leading figure in neonatology research. He also has significant experience in leading interdisciplinary teams and is recognized for his commitment to ethical practices in clinical research.

Research Focus :

Dr. Poets’ research encompasses various pediatric and neonatal areas, focusing on breathing control, sleep apnea, intermittent hypoxia, and perinatal outcomes. His interest in congenital malformations has led to groundbreaking research on Robin sequence and craniofacial malformations. He is also deeply engaged in SIDS research, perinatal epidemiology, innate immunity, and ethical considerations in neonatal care. Furthermore, he actively participates in and leads multicenter clinical trials. He served as the Coordinator and Co-Principal Investigator (Co-PI) for NEuroSIS, a large EU-funded multicenter study on inhaled steroids for bronchopulmonary dysplasia (BPD) prevention. He is also on the steering committee for several major trials, including the COT and ETTNO trials, and serves on the Data Safety Monitoring Board (DSMB) of the DOXA and HiLo international trials.

🔬Awards:

Over his distinguished career, Dr. Poets has published over 440 research articles cited in PubMed and contributed to over 120 review articles. His influential work in neonatology, particularly in multicenter clinical trials, has earned him numerous accolades in the medical community. His leadership in establishing the Interdisciplinary Centre for Cleft Palate and Craniofacial Malformations and his research contributions to neonatal care highlight his commitment to advancing pediatric medicine on both a national and international scale.

Conclusion:

Given his extensive experience in innovative neonatal and pediatric research, Prof. Poets is a strong contender for the Research for Excellence in Innovation Award. His leadership in large clinical trials, commitment to interdisciplinary care, and international collaborations have created a lasting impact on pediatric health care. Addressing emerging technologies and ethical concerns could further strengthen his candidacy for future innovation awards.

Publications :

  • Delineating morbidity patterns in preterm infants at near-term age using a data-driven approach
    Ciora, O.-A., Seegmüller, T., Fischer, J.S., Ahmidi, N., Hilgendorff, A.
    BMC Pediatrics, 2024, 24(1), 249.

 

  • Detailed statistical analysis plan for ALBINO: effect of Allopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome — a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III)
    Engel, C., Rüdiger, M., Benders, M.J.N.L., Stocker, M., Riedel, T.
    Trials, 2024, 25(1), 81.

 

  • Failure of an electric rocking device to improve neonatal sleep
    Poets, C.F., Roller, P., Neukamm, A.-C., Quante, M.
    Acta Paediatrica, International Journal of Paediatrics, 2024, 113(8), pp. 1791–1795.

 

  • Simulated model revealed significant continuous positive airway pressure fluctuations with facemasks
    Sterzik, H., Kumpf, M., Poets, C.F., Haase, B.
    Acta Paediatrica, International Journal of Paediatrics, 2024, 113(7), pp. 1531–1533.

 

  • Pulse oximetry signal loss during hypoxic episodes in preterm infants receiving automated oxygen control
    Langanky, L.O., Kreutzer, K.B., Poets, C.F., Franz, A.R., Schwarz, C.E.
    European Journal of Pediatrics, 2024, 183(7), pp. 2865–2869.

 

  • Randomised crossover study on pulse oximeter readings from different sensors in very preterm infants
    Maiwald, C.A., Schwarz, C.E., Böckmann, K., Poets, C.F., Franz, A.
    Archives of Disease in Childhood: Fetal and Neonatal Edition, 2024, 109(4), pp. 391–396.

 

  • Safe baby sleep in advertising | Sicherer Babyschlaf in der Werbung
    Kalus, E., Poets, C.F., Quante, M.
    Somnologie, 2024, 28(2), pp. 99–102.

 

  • Influence of malocclusion and orthodontic treatment in the masticatory efficiency of patients with craniofacial disorders
    Weismann, C., Schmidt, M., Effert, J., Koos, B., Aretxabaleta, M.
    Heliyon, 2024, 10(6), e28321.

 

  • Impact of flow-dependent imposed work of breathing for optimising neonatal CPAP with a T-piece device
    Sterzik, H., Arand, J., Molnar, K., Poets, C.F., Haase, B.
    Acta Paediatrica, International Journal of Paediatrics, 2024.

 

  • Facial growth dynamics dictate optimal facemask fitting during the first year of life
    Haase, B., Badinska, A.-M., Sowula, J., Poets, C.F., Wiechers, C.
    Acta Paediatrica, International Journal of Paediatrics, 2024.